Skip to main content
Livermore
Livermore
ZHEN

Tvardi Therapeutics, Inc.

TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001346830

No open-market purchases or sales by Tvardi Therapeutics, Inc. insiders were filed in the last 90 days; 57 institutions reported holding it in 13F filings for Q2 2026, worth $4.24M in total; no superinvestor holds it.

Holders of 5% or more of TVRD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tvardi Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TVRD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Sporos Bioventures LLC13G8.95%837.6K sharesNewAug 8, 20251 filingAug 8, 2025SEC
Solas Tvardi Sidecar LLC13G8.10%761.3K sharesNewApr 22, 20251 filingApr 22, 2025SEC
Slate Path Capital LP13G7.50%704.1K sharesNewAug 14, 20251 filingAug 14, 2025SEC
Tweardy David John13G7.00%652.4K sharesNewMay 2, 20251 filingMay 2, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

32 Schedule 13D and 13G filings on Tvardi Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TVRD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 17, 20265:30 PM ETDePinho Ronald A13G/A4.50%426.2K shares−2.20 ppfrom 6.70%Below 5%Dec 31, 2025SEC
Nov 14, 20255:01 PM ETDePinho Ronald A13G/A6.70%626.2K shares−1.60 ppfrom 8.30%Sep 30, 2025SEC
Aug 14, 20254:15 PM ETSlate Path Capital LPand 1 other13G7.50%704.1K sharesNewJun 30, 2025SEC
Aug 8, 20254:30 PM ETSporos Bioventures LLC13G8.95%837.6K sharesNewApr 15, 2025SEC
Aug 5, 20258:04 PM ETTweardy Samuel David13G/A3.40%315.7K shares−6.70 ppfrom 10.10%Below 5%Jul 7, 2025SEC
Jun 2, 20259:04 AM ETDePinho Ronald A13G8.30%781.0K sharesNewApr 15, 2025SEC
May 2, 20254:24 PM ETTweardy Samuel David13G10.10%947.0K sharesNewApr 15, 2025SEC
May 2, 20254:21 PM ETTweardy David John13G7.00%652.4K sharesNewApr 15, 2025SEC
Apr 22, 20252:26 PM ETSolas Tvardi Sidecar LLCand 2 others13G8.10%761.3K sharesNewApr 15, 2025SEC
Apr 16, 20254:15 PM ETVifor (International) Ltdand 1 other13D/A2.20%205.5K shares−11.30 ppfrom 13.50%Below 5%Apr 15, 2025SEC
Dec 18, 20245:10 PM ETVifor (International) Ltdand 1 other13D/A13.50%7.40M shares–Dec 17, 2024SEC
Oct 30, 2024Vifor (International) Ltd13DOld format–––SEC
Jul 8, 20244:32 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 13, 2024Bain Capital Life Sciences Opportunities III, LP13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jan 29, 20243:26 PM ETBlackRock Inc.13G/AOld format–––SEC
Jul 25, 2023Vifor (International) Ltd13G/AOld format–––SEC
Jul 7, 20234:35 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Jan 26, 20238:52 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 20, 20239:43 AM ETBlackRock Inc.13G/AOld format–––SEC
Nov 18, 2022Bain Capital Life Sciences Opportunities III, LP13GOld format–New–SEC
Feb 15, 2022First Manhattan Co13G/AOld format–––SEC
Feb 14, 2022RHO Ventures VI LP13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13GOld format–New–SEC
Jan 28, 20221:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 21, 2021Vifor (International) Ltd13G/AOld format–––SEC
May 7, 20215:09 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 16, 2021First Manhattan Co13GOld format–New–SEC
Feb 16, 2021Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 12, 2021RHO Ventures VI LP13G/AOld format–––SEC
Jan 28, 20215:56 PM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Tvardi Therapeutics, Inc. shares.

No Form 144 notices for Tvardi Therapeutics, Inc. are on file.